With superbug scourge looming, global group bets on biotechs to turn the tide

(By Damian Garde and Ed Silverman for STAT)

Gunning to beat back a global scourge of superbugs, a transatlantic group is committing tens of millions of dollars, some of that from American taxpayers, to back biotech startups developing novel antibiotics. Read article here….

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.